Oncogene 33 , 23542362 (2014)
Listen to your gut Generally, when you go on a medication like Zepbound, your tastes change , Dr
Key insights from The Atlantic: 14 million adults on Medicaid suffer from obesity, but only 13 states currently cover GLP-1s for weight management These drugs reduce weight by 15-20% and show benefits for diabetes, cardiovascular disease, liver/kidney disease, and even substance abuse Budget fears may be overblown: with Medicaid negotiation power and falling prices, costs could be offset by 27%+ through reduced healthcare spending At projected Medicaid prices (~$235/month), covering 10% of eligible patients would increase Medicaid spending by just 0.4% For communities like zip code 78207 facing a diabetes crisis, this isnt just about weight lossits about access to life-saving medication that could add 3-4 years to life expectancy while reducing complications from multiple chronic conditions
Reusing Syringes: This should be obvious, but it happens
I am arguing that the question of who should receive them has not been asked with nearly enough precision, and that a baseline GLP-1 measurement is an obvious, low-cost starting point
